Evidence map›Paper›PMID 39713407›Full record

ArticlebioRxiv : the preprint server for biology2025

UniFORM: Towards Universal ImmunoFluorescence Normalization for Multiplex Tissue Imaging.

Kunlun Wang, Kaoutar Ait-Ahmad, Sam Kupp, Zachary Sims, Eric Cramer, Zeynep Sayar, Jessica Yu, Melissa H Wong, Gordon B Mills, S Ece Eksi and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kunlun WangCancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR, USA.ORCID 0009-0009-3486-9752
Kaoutar Ait-AhmadCancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR, USA.ORCID 0009-0004-1713-0706
Sam KuppCancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR, USA.
Zachary SimsDepartment of Biomedical Engineering and Computational Biology Program, OHSU, Portland, OR, USA.ORCID 0000-0002-8866-5722
Eric CramerDepartment of Biomedical Engineering and Computational Biology Program, OHSU, Portland, OR, USA.ORCID 0000-0003-2085-3679
Zeynep SayarCancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR, USA.ORCID 0000-0003-1705-8906
Jessica YuCancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR, USA.
Melissa H WongDepartment of Cell, Developmental and Cancer Biology, OHSU, Portland, OR, USA.ORCID 0000-0001-9628-0884
Gordon B MillsKnight Cancer Institute, OHSU, Portland, OR, USA.ORCID 0000-0002-0144-9614
S Ece EksiCancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR, USA.ORCID 0000-0001-9243-6036
Young Hwan ChangDepartment of Biomedical Engineering and Computational Biology Program, OHSU, Portland, OR, USA.ORCID 0000-0001-8764-1959

Funding

Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY · 2018 to 2023
$9.7M
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive diseaseR01CA253860 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CHANG, YOUNG HWAN, WONG, MELISSA H. · 2021 to 2025
$3.0M
The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune responseR01CA276224 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Guillermo N Armaiz-Pena, Shelley S Tworoger · 2023 to 2026
$2.0M
NCI NIH HHS R01 CA253860NCI NIH HHS R01 CA276224NCI NIH HHS U2C CA233280
6 · The paper itself

Abstract

Multiplexed tissue imaging (MTI) technologies enable high-dimensional spatial analysis of tumor microenvironments but face challenges with technical variability in staining intensities. Existing normalization methods, including Z-score, ComBat, and MxNorm, often fail to account for the heterogeneous, right-skewed expression patterns of MTI data, compromising signal alignment and downstream analyses. We present UniFORM, a non-parametric, Python-based pipeline that uses an automated rigid landmark functional data registration approach for normalizing both feature- and pixel-level MTI data. Designed specifically for the distributional characteristics of MTI datasets, UniFORM operates without prior distributional assumptions and performs robustly regardless of distribution modality, including both unimodal and bimodal patterns. It removes technical variation by aligning the biologically invariant component of the signal, typically the negative (non-expressing) population, while preserving biologically meaningful variation in the positive population, thereby maintaining tissue-specific expression patterns essential for downstream analysis. Benchmarking across three distinct MTI platform datasets demonstrates that UniFORM outperforms existing methods in mitigating batch effects while maintaining biological signal fidelity. This is evidenced by improved marker distribution alignment and positive population preservation, enhanced kBET and Silhouette scores, and improved downstream analyses such as UMAP visualizations and Leiden clustering. UniFORM also introduces a novel guided fine-tuning option for complex and heterogeneous datasets. Although optimized for fluorescence-based platforms, UniFORM provides a scalable and robust solution for MTI data normalization, enabling accurate and biologically meaningful interpretations.

Identifiers

PMID39713407
PMCPMC11661071

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.